Mytrex Health Technologies, Inc.

TPEX:4431 Stock Report

Market Cap: NT$896.9m

Mytrex Health Technologies Balance Sheet Health

Financial Health criteria checks 4/6

Mytrex Health Technologies has a total shareholder equity of NT$671.9M and total debt of NT$68.3M, which brings its debt-to-equity ratio to 10.2%. Its total assets and total liabilities are NT$1.3B and NT$654.6M respectively.

Key information

10.2%

Debt to equity ratio

NT$68.31m

Debt

Interest coverage ration/a
CashNT$347.96m
EquityNT$671.92m
Total liabilitiesNT$654.59m
Total assetsNT$1.33b

Recent financial health updates

No updates

Recent updates

The Trend Of High Returns At Mytrex Health Technologies (GTSM:4431) Has Us Very Interested

Apr 01
The Trend Of High Returns At Mytrex Health Technologies (GTSM:4431) Has Us Very Interested

Could The Market Be Wrong About Mytrex Health Technologies, Inc. (GTSM:4431) Given Its Attractive Financial Prospects?

Feb 07
Could The Market Be Wrong About Mytrex Health Technologies, Inc. (GTSM:4431) Given Its Attractive Financial Prospects?

Shareholders of Mytrex Health Technologies (GTSM:4431) Must Be Delighted With Their 438% Total Return

Jan 04
Shareholders of Mytrex Health Technologies (GTSM:4431) Must Be Delighted With Their 438% Total Return

Should You Rely On Mytrex Health Technologies's (GTSM:4431) Earnings Growth?

Dec 07
Should You Rely On Mytrex Health Technologies's (GTSM:4431) Earnings Growth?

Financial Position Analysis

Short Term Liabilities: 4431's short term assets (NT$852.9M) exceed its short term liabilities (NT$539.4M).

Long Term Liabilities: 4431's short term assets (NT$852.9M) exceed its long term liabilities (NT$115.2M).


Debt to Equity History and Analysis

Debt Level: 4431 has more cash than its total debt.

Reducing Debt: 4431's debt to equity ratio has increased from 4.3% to 10.2% over the past 5 years.

Debt Coverage: 4431's debt is well covered by operating cash flow (113.7%).

Interest Coverage: Insufficient data to determine if 4431's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/18 04:50
End of Day Share Price 2025/01/17 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mytrex Health Technologies, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution